These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 25194909

  • 1. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
    Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA.
    Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
    [Abstract] [Full Text] [Related]

  • 2. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA.
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [Abstract] [Full Text] [Related]

  • 3. Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.
    Moschini M, Dell' Oglio P, Capogrosso P, Cucchiara V, Luzzago S, Gandaglia G, Zattoni F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.
    Clin Genitourin Cancer; 2015 Dec; 13(6):562-7. PubMed ID: 26004301
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [Abstract] [Full Text] [Related]

  • 5. Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy.
    Moschini M, Soria F, Abufaraj M, Foerster B, D'Andrea D, Damiano R, Klatte T, Montorsi F, Briganti A, Colombo R, Gallina A, Shariat SF.
    Clin Genitourin Cancer; 2017 Aug; 15(4):e681-e688. PubMed ID: 28162943
    [Abstract] [Full Text] [Related]

  • 6. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF.
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [Abstract] [Full Text] [Related]

  • 7. Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage.
    Buchner A, Grimm T, Schneevoigt BS, Wittmann G, Kretschmer A, Jokisch F, Grabbert M, Apfelbeck M, Schulz G, Gratzke C, Stief CG, Karl A.
    Scand J Urol; 2017 Apr; 51(2):130-136. PubMed ID: 28332428
    [Abstract] [Full Text] [Related]

  • 8. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Kluth LA, Xylinas E, Rieken M, El Ghouayel M, Sun M, Karakiewicz PI, Lotan Y, Chun FK, Boorjian SA, Lee RK, Briganti A, Rouprêt M, Fisch M, Scherr DS, Shariat SF.
    BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
    [Abstract] [Full Text] [Related]

  • 9. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
    Diamantopoulos LN, Sekar RR, Holt SK, Khaki AR, Miller NJ, Gadzinski A, Nyame YA, Vakar-Lopez F, Tretiakova MS, Psutka SP, Gore JL, Lin DW, Schade GR, Hsieh AC, Lee JK, Yezefski T, Schweizer MT, Cheng HH, Yu EY, True LD, Montgomery RB, Grivas P, Wright JL.
    Urol Oncol; 2021 Aug; 39(8):496.e1-496.e8. PubMed ID: 33551249
    [Abstract] [Full Text] [Related]

  • 10. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ, Al-Daghmin A, Zhuo S, Mehboob Z, Wang K, Wilding G, Kauffman E, Guru KA.
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [Abstract] [Full Text] [Related]

  • 11. Risk factors and outcomes of urethral recurrence following radical cystectomy.
    Boorjian SA, Kim SP, Weight CJ, Cheville JC, Thapa P, Frank I.
    Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
    [Abstract] [Full Text] [Related]

  • 12. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study.
    Furrer MA, Fellmann A, Schneider MP, Thalmann GN, Burkhard FC, Wuethrich PY.
    Eur Urol Focus; 2018 Dec; 4(6):916-923. PubMed ID: 28951117
    [Abstract] [Full Text] [Related]

  • 13. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
    Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, Bladder Cancer Research Consortium.
    BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
    [Abstract] [Full Text] [Related]

  • 14. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group.
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [Abstract] [Full Text] [Related]

  • 15. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Babjuk M, Bachmann A, Scherr DS, Shariat SF.
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [Abstract] [Full Text] [Related]

  • 16. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA.
    Urol Oncol; 2016 Jan; 34(1):4.e1-9. PubMed ID: 26329815
    [Abstract] [Full Text] [Related]

  • 17. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
    Chalfin HJ, Liu JJ, Gandhi N, Feng Z, Johnson D, Netto GJ, Drake CG, Hahn NM, Schoenberg MP, Trock BJ, Scott AV, Frank SM, Bivalacqua TJ.
    Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
    [Abstract] [Full Text] [Related]

  • 18. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.
    Gandaglia G, Popa I, Abdollah F, Schiffmann J, Shariat SF, Briganti A, Montorsi F, Trinh QD, Karakiewicz PI, Sun M.
    Eur Urol; 2014 Sep; 66(3):561-8. PubMed ID: 24486024
    [Abstract] [Full Text] [Related]

  • 19. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
    Mason RJ, Frank I, Bhindi B, Tollefson MK, Thompson RH, Karnes RJ, Tarrell R, Thapa P, Boorjian SA.
    World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
    [Abstract] [Full Text] [Related]

  • 20. The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma.
    Sadeghi N, Badalato GM, Hruby G, Kates M, McKiernan JM.
    Can J Urol; 2012 Oct; 19(5):6443-9. PubMed ID: 23040626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.